Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
. 2006 Dec 5;28(10):467–470. doi: 10.1002/clc.4960281005

Serum troponin I level after external electrical direct current synchronized cardioversion in patients with normal or reduced ejection fraction: No evidence of myocytes injury

Roberto Cemin 1,, Werner Rauhe 1, Massimiliano Marini 2, Felix Pescoller 1, Walter Pitscheider 1
PMCID: PMC6654131  PMID: 16274094

Abstract

Background: External electrical cardioversion (EEC) has been suggested as a cause of myocardial damage, but results from several previously published studies are conflicting.

Hypothesis: The purpose of the study was to evaluate myocardial electrical injury caused by EEC.

Methods: After elective EEC for atrial fibrillation (AF), cardiac troponin I (cTnI) was measured in 193 consecutive patients attending the Cardiology Department of the San Maurizio Hospital of Bolzano for elective EEC of AF over a period of 13 months. External electrical cardioversion was performed by one of the attending cardiologists with a synchronized monophasic defibrillator. Blood sample for cTnI was taken 18—20h after EEC.

Results: Of 193 patients, 183 (95%) were successfully cardioverted. Mean number of shocks was 1.46 and the mean total energy discharged per procedure was 379.4 ± 229.2 J. Cardiac troponin remained under the limit of confidence for all patients with a mean value of 0.017 ± 0.021 mcrg/l. No correlation between total energy delivered and cTnI was found. In the subgroup of patients with low ejection fraction, none had elevated cTnI, and no difference in cTnI values between these and patients with an ejection fraction > 40% was found.

Conclusions: The results of our analysis indicate that EEC caused no myocardial injury even in patients with low ejection fraction.

Keywords: atrial fibrillation, external electrical cardioversion, myocardial damage, ventricular function

Full Text

The Full Text of this article is available as a PDF (59.7 KB).

References

  • 1. Garré L, Alvarez A, Rubio M, Pellegrini A, Caridi M, Berardi A, Lazzaro C, Blanco P, Menehem C, Diaz M: Use of cardiac Troponin T rapid assay in the diagnosis of myocardial injury secondary to electrical cardioversion. Clin Cardiol 1997; 20: 619–621 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Morris J, Peter RH, McIntosh HD: Electrical conversion of atrial fibrillation. Immediate and long‐term results and selection of patients. Ann Intern Med 1966; 65: 216–219 [Google Scholar]
  • 3. Cobb FR, Wallace AG, Wagner GS: Cardiac inotropic and coronary vascular responses to countershock. Evidence of excitation of intracardiac nerves. Circ Res 1968; 23: 731–742 [DOI] [PubMed] [Google Scholar]
  • 4. Allan JJ, Feld R, Russell A, Ladenson JH, Rogers MA, Kerber RE, Jaffe AS: Cardiac Troponin I levels are normal or minimally elevated after transthoracic cardioversion. J Am Coll Cardiol 1997; 30: 1052–1056 [DOI] [PubMed] [Google Scholar]
  • 5. Lund M, French JK, Johnson RN, Williams BF, White HD: Serum troponins T and I after elective cardioversion. Eur Heart J 2000; 21: 245–253 [DOI] [PubMed] [Google Scholar]
  • 6. Bonnefoy E, Chevalier P, Kirkorian G, Guidolet J, Marchand A, Touboul P: Cardiac troponin I does not increase after cardioversion. Chest 1997; 111: 15–18 [DOI] [PubMed] [Google Scholar]
  • 7. Del Rey Sanchez JM, Hernandez Madrid A, Gonzales Rebollo JM, Pena Perez G, Rodriguez A, Savova D, Cano Calabria L, Cabeza P, Cascon Perez JD, Gomez Bueno M, Mercander J, Ripoll E, Moro C: External and internal cardioversion: Comparative, prospective evaluation of cell damage by means of troponin I. Rev Esp Cardiol 2002; 55 (3): 227–234 [DOI] [PubMed] [Google Scholar]
  • 8. Van Gelder IC, Crijins HJ, Van Der Laarse A, Van Gilst WH, Lie KI: Incidence and clinical significance of ST‐segment elevation after electrical cardioversion of atrial fibrillation and flutter. Am Heart J 1991; 121: 51–56 [DOI] [PubMed] [Google Scholar]
  • 9. Georges JL, Spentchian M, Caubel C, Collignon I, Schwob J, Livarek B, Normand JP: Time course of troponin I, myoglobin and cardiac enzyme release after electrical cardioversion. Am J Cardiol 1996; 78: 825–826 [DOI] [PubMed] [Google Scholar]
  • 10. Vikenes K, Omvik P, Farstad M, Nordrehaug JE: Cardiac biochemical markers after cardioversion of atrial fibrillation or atrial flutter. Am Heart J 2000; 140 (4): 690–696 [DOI] [PubMed] [Google Scholar]
  • 11. Rao AC, Naeem N, John C, Collison PO, Canepa‐Anson R, Joseph SP: Direct current cardioversion does not cause cardiac damage: Evidence from cardiac troponin T estimation. Heart 1998; 80: 229–230 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Neumayr G, Hagn C, Ganzer H, Friedrich G, Pachlaner C, Joannidis M, Schratzberger P, Wiedermann CJ: Plasma levels of troponin T after electrical cardioversion of atrial fibrillation and flutter. Am J Cardiol 1997; 15 (80): 1367–1369 [DOI] [PubMed] [Google Scholar]
  • 13. Greaves K, Crake T: Cardiac troponin T does not increase after electrical cardioversion for atrial fibrillation or atrial flutter. Heart 1998; 80: 226–228 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Grubb NR, Cuthbert D, Cawood P, Flapan A, Fox KA: Effect of DC shock on serum levels of total creatine kinase, MB‐creatine kinase mass and troponin T. Resuscitation 1998; 36: 193–199 [DOI] [PubMed] [Google Scholar]
  • 15. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan: National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, classification and stratification. Ann Intern Med 2003; 139: 137–147 [DOI] [PubMed] [Google Scholar]
  • 16. Schiller NB, Shah PM, Crawford M, De Maria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I: Recommandations for quantitation of the left ventricle by two‐dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two‐Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358–367 [DOI] [PubMed] [Google Scholar]
  • 17. Adams JE, Bodor GS, Davila‐Roman VG, Delmez JA, Apple FS, Ladenson JH, Jaffe AS: Cardiac troponin I: A marker with high specificity for cardiac injury. Circulation 1993; 88: 101–106 [DOI] [PubMed] [Google Scholar]
  • 18. Bertinchant JP, Larue C, Pernel I, Ledermann B, Fabbro‐Peray P, Beck L, Calzolari C, Trinquiere S, Nigond J, Pau B: Release kinetics of serum cardiac troponin I in ischaemic myocardial injury. Clin Biochem 1996; 29 (6): 587–594 [DOI] [PubMed] [Google Scholar]
  • 19. Joglar JA, Hamdan MH, Ramaswamy K, Zagrodzky JD, Sheehan C, Nelson LL, Andrews TC, Page RL: Initial energy for elective external car dioversion of persistent atrial fibrillation. Am J Cardiol 2000; 86 (3): 348–350 [DOI] [PubMed] [Google Scholar]
  • 20. Ricard P, Levy S, Boccara G, Lakhal E, Bardy G: External cardioversion of atrial fibrillation: Comparison of biphasic vs. monophasic waveform shocks. Europace 2001; 3: 96–99 [DOI] [PubMed] [Google Scholar]
  • 21. Volpi A, Cavalli A, Santoro E, Tognoni G: Incidence and prognosis of secondary ventricular fibrillation in acute myocardial infarction. Evidence for a protective effect of thrombotic therapy. Circulation 1990; 82: 1279–1288 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES